# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-22-009871
Filing Date
2022-03-17
Accepted
2022-03-17 09:36:43
Documents
14
Period of Report
2022-03-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | ny20003153x5_8k.htm iXBRL | 8-K | 28179
2 | EXHIBIT 3.1 | ny20003153x5_ex3-1.htm | EX-3.1 | 1180
6 |  | ny20003153x5_ex3-1img01.jpg | GRAPHIC | 966712
| Complete submission text file | 0001140361-22-009871.txt |  | 1421750

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | neog-20220314.xsd | EX-101.SCH | 3917
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | neog-20220314_lab.xml | EX-101.LAB | 23289
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | neog-20220314_pre.xml | EX-101.PRE | 16546
8 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20003153x5_8k_htm.xml | XML | 4213

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 22746994
SIC: 2835 In Vitro & In Vivo Diagnostic Substances